APA

Petit J. H., Gluck C., Kiger W. S., Henry D. L., Karasiewicz C., Talcott J., Berg S., Holupka E. & Kaplan I. (20080922). Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity. : Urologic oncology.

Chicago

Petit Joshua H, Gluck Clifford, Kiger W S, Henry D Laury, Karasiewicz Carol, Talcott James, Berg Solomon, Holupka Edward and Kaplan Irving. 20080922. Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity. : Urologic oncology.

Harvard

Petit J. H., Gluck C., Kiger W. S., Henry D. L., Karasiewicz C., Talcott J., Berg S., Holupka E. and Kaplan I. (20080922). Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity. : Urologic oncology.

MLA

Petit Joshua H, Gluck Clifford, Kiger W S, Henry D Laury, Karasiewicz Carol, Talcott James, Berg Solomon, Holupka Edward and Kaplan Irving. Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity. : Urologic oncology. 20080922.